These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12750756)

  • 1. [Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain].
    Bouza E; Garcia-Garrote F; Cercenado E; Marín M; Díaz MS; Sánchez Romero I; Vindel A;
    Rev Esp Quimioter; 2003 Mar; 16(1):41-52. PubMed ID: 12750756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
    Sánchez-Romero I; Cercenado E; Cuevas O; García-Escribano N; García-Martínez J; Bouza E;
    Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Castellón, Spain].
    Gomila Sard B; Pardo Serrano FJ; Moreno Muñoz R; Celades Porcar E; García del Busto Remón A
    Rev Esp Quimioter; 2006 Mar; 19(1):60-4. PubMed ID: 16688293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ; Tirado Balaguer MD; García Zúñiga ED; Granados Ortega J; Campos Aznar A; Moreno Muñoz R
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
    Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
    Ray GT; Baxter R; DeLorenze GN
    Clin Infect Dis; 2005 Aug; 41(4):441-9. PubMed ID: 16028150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of Pseudomonas aeruginosa isolated from hospital infections to antibiotics].
    Gniadkowski M; Skoczyńska A; Fiett J; Trzciński K; Hryniewicz W
    Pol Merkur Lekarski; 1998 Dec; 5(30):346-50. PubMed ID: 10101521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents].
    Gamero Delgado MC; García-Mayorgas AD; Rodríguez F; Ibarra A; Casal M
    Rev Esp Quimioter; 2007 Jun; 20(2):230-3. PubMed ID: 17893761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa.
    Sevillano E; Valderrey C; Canduela MJ; Umaran A; Calvo F; Gallego L
    Pathol Biol (Paris); 2006; 54(8-9):493-7. PubMed ID: 17027190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
    Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
    Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
    Hsueh PR; Tseng SP; Teng LJ; Ho SW
    Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.